Creating Value by Overcoming Treatment Barriers View previous quarters - Today Latest News View all press releases 07.29.26 Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET Read More 07.07.26 Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism Read More 05.13.26 Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Read More Events View all events Upcoming Events 08.12.26 8:00 AM EDT Q2 2026 Aquestive Therapeutics, Inc. Earnings Conference Call Past Events 05.14.26 8:00 AM EDT Q1 2026 Aquestive Therapeutics, Inc. Earnings Conference Call 03.10.26 8:25 AM EDT Citizens Life Sciences Conference Presentations View all presentations Corporate Presentation – February 2026 Anaphylm™ (dibutepinephrine) Sublingual Film Complete Response Letter Supplemental Material 1.1 MB Anaphylm Pre-NDA Meeting Supplemental Material 525.4 KB
07.29.26 Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET Read More
07.07.26 Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism Read More
05.13.26 Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Read More
